| Literature DB >> 6952962 |
S D Fosså, B Wik, E Bae, H H Lien.
Abstract
In 20 patients with measurable metastatic renal cancer 4'-epi-doxorubicin (Adriamycin) administration (75 mg/m2, every 3 weeks) did not result in any tumor remission. Hematologic and gastrointestinal toxicity was generally mild to moderate. Anthracycline-induced cardiac side effects were not observed in any of the patients.Entities:
Mesh：
Substances：
Year: 1982 PMID： 6952962
Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960